[Gastro-intestinal toxicity of rofecoxib].
Lima Rodríguez
E M
EM
Medicina Familiar y Comunitaria, Hospital Perpetuo Socorro, Badajoz, España.
Calvo Romero
J M
JM
D000368:Aged; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D064420:Drug-Related Side Effects and Adverse Reactions; D004381:Duodenal Ulcer / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010438:Peptic Ulcer Hemorrhage / Q000139:chemically induced*; D013450:Sulfones / Q000009:adverse effects*
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib
Gastroenterology. 1999 Oct;117(4):776-83
10500058
Gastroenterology. 1997 Feb;112(2):387-97
9024292
N Engl J Med. 1999 Jun 17;340(24):1888-99
10369853
Curr Med Res Opin. 2003;19(4):288-97
12841921
J Rheumatol. 2002 Mar;29(3):467-73
11908558
Gut. 2003 Jun;52(6):820-6
12740337
N Engl J Med. 2000 Nov 23;343(21):1520-8, 2 p following 1528
11087881
JAMA. 1999 Nov 24;282(20):1929-33
10580458
Curr Pharm Des. 2003;9(27):2213-9
14529402
N Engl J Med. 2001 Aug 9;345(6):433-42
11496855
Rheumatology (Oxford). 2003 May;42(5):622-31
12709537
BMJ. 2002 Sep 21;325(7365):624
12242172